Viewing Study NCT06916494


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-01-25 @ 6:33 AM
Study NCT ID: NCT06916494
Status: RECRUITING
Last Update Posted: 2025-04-10
First Post: 2025-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
Sponsor:
Organization: